You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

CLINICAL TRIALS PROFILE FOR ESTRADIOL CYPIONATE; MEDROXYPROGESTERONE ACETATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for estradiol cypionate; medroxyprogesterone acetate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01699022 ↗ Pharmacokinetic and Pharmacodynamic Study of Cyclofem Completed Sun Pharmaceutical Industries Limited Phase 1/Phase 2 2010-06-01 Cyclofem® is a monthly injectable contraceptive containing 25 mg of medroxyprogesterone acetate (MPA) and 5 mg of estradiol cypionate (E2C), a long-acting ester of estradiol. The current study will assess the steady-state pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate (MPA) and estradiol (E2) after administration of Cyclofem® and will provide critical information to determine similar bioavailability of Cyclofem to Lunelle in women residing in the United States of America.
NCT03443089 ↗ Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate Completed Biolab Sanus Farmaceutica Phase 1 2017-03-31 This clinical trial evaluated the comparative bioavailability of two injectable suspension formulations of medroxyprogesterone acetate + estradiol cypionate, a test (Depomês®, 25 mg/mL medroxyprogesterone acetate + 5 mg/mL estradiol cypionate, Biolab Sanus Farmacêutica Ltda.) and a reference formulation (Cyclofemina®, 25 mg/0.5 mL medroxyprogesterone acetate + 5 mg/0.5 mL estradiol cypionate, Millet Roux Ltda.) in healthy female volunteers after a single intramuscular dose administration. In addition, this study also evaluated the safety and tolerability of these drugs.
NCT03443089 ↗ Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate Completed Galeno Desenvolvimento de Pesquisas Clínicas Phase 1 2017-03-31 This clinical trial evaluated the comparative bioavailability of two injectable suspension formulations of medroxyprogesterone acetate + estradiol cypionate, a test (Depomês®, 25 mg/mL medroxyprogesterone acetate + 5 mg/mL estradiol cypionate, Biolab Sanus Farmacêutica Ltda.) and a reference formulation (Cyclofemina®, 25 mg/0.5 mL medroxyprogesterone acetate + 5 mg/0.5 mL estradiol cypionate, Millet Roux Ltda.) in healthy female volunteers after a single intramuscular dose administration. In addition, this study also evaluated the safety and tolerability of these drugs.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for estradiol cypionate; medroxyprogesterone acetate

Condition Name

Condition Name for estradiol cypionate; medroxyprogesterone acetate
Intervention Trials
Contraception 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for estradiol cypionate; medroxyprogesterone acetate
Intervention Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for estradiol cypionate; medroxyprogesterone acetate

Trials by Country

Trials by Country for estradiol cypionate; medroxyprogesterone acetate
Location Trials
Brazil 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for estradiol cypionate; medroxyprogesterone acetate
Location Trials
Virginia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for estradiol cypionate; medroxyprogesterone acetate

Clinical Trial Phase

Clinical Trial Phase for estradiol cypionate; medroxyprogesterone acetate
Clinical Trial Phase Trials
Phase 1/Phase 2 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for estradiol cypionate; medroxyprogesterone acetate
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for estradiol cypionate; medroxyprogesterone acetate

Sponsor Name

Sponsor Name for estradiol cypionate; medroxyprogesterone acetate
Sponsor Trials
Sun Pharmaceutical Industries Limited 1
Biolab Sanus Farmaceutica 1
Galeno Desenvolvimento de Pesquisas Clínicas 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for estradiol cypionate; medroxyprogesterone acetate
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.